• J.D., University of Michigan, 2015
  • Ph.D., Genetic, Molecular and Cellular Biology, University of Southern California, 2010
  • M.S., Computer Science, University of Southern California, 2010
  • B.S., Majors in Biochemistry, Chemistry, and Mathematics, University of Cape Town, 2003
  • California
  • U.S. Patent and Trademark Office


Dr. Paul Chang is an associate in the Intellectual Property Practice Group in the firm's San Diego (Del Mar) office.

Paul helps clients protect their innovations during IP procurement and beyond. With advanced training in life sciences as well as computer science, Paul is a go-to person for complex and inter-disciplinary technologies. Clients entrust him with securing patent protections in the areas of genomics, bioinformatics and personalized medicine – ranging from multiomics data collection, processing, analysis, and visualization and next-generation sequencing technologies to disease diagnosis and treatment. Paul works extensively on platform biotechnologies, such as flow cytometry, mass spectrometry, and microfluidics. He also has extensive experience in big data mining and analytics, artificial intelligence, and machine learning – including computer vision, autonomous driving, augmented reality, and product recommendations – and blockchain, cryptocurrency, user interface, computer security, database, image processing, and ridesharing.

Beyond IP procurement, Paul works with clients on validity and invalidity analyses, infringement studies, IP due diligence investigations, clearance investigations, and licensing agreements and strategies. Paul firmly believes that successful IP strategies must support the underlining business objectives of the clients, whether individual inventors, academic institutions, startups, or multinational corporations.